Harel Insurance Investments & Financial Services Ltd. Purchases 13,881 Shares of Rocket Lab Corporation $RKLB

Harel Insurance Investments & Financial Services Ltd. increased its holdings in Rocket Lab Corporation (NASDAQ:RKLB) by 23.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 73,746 shares of the rocket manufacturer’s stock after purchasing an additional 13,881 shares during the quarter. Harel Insurance Investments & Financial Services Ltd.’s holdings in Rocket Lab were worth $3,533,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Wilmington Savings Fund Society FSB bought a new stake in shares of Rocket Lab in the 3rd quarter worth approximately $25,000. Sound Income Strategies LLC bought a new position in shares of Rocket Lab during the third quarter valued at approximately $27,000. EverSource Wealth Advisors LLC lifted its stake in Rocket Lab by 109.5% in the second quarter. EverSource Wealth Advisors LLC now owns 796 shares of the rocket manufacturer’s stock worth $28,000 after acquiring an additional 416 shares during the period. Financial Consulate Inc. bought a new stake in Rocket Lab in the third quarter valued at $35,000. Finally, Atlantic Union Bankshares Corp purchased a new position in Rocket Lab during the 2nd quarter valued at $36,000. Institutional investors own 71.78% of the company’s stock.

Wall Street Analysts Forecast Growth

RKLB has been the subject of several research analyst reports. Robert W. Baird began coverage on shares of Rocket Lab in a research report on Wednesday, October 15th. They issued an “outperform” rating and a $83.00 target price for the company. KeyCorp lowered shares of Rocket Lab from an “overweight” rating to a “sector weight” rating in a report on Thursday. Cantor Fitzgerald reiterated an “overweight” rating on shares of Rocket Lab in a report on Wednesday, December 3rd. Stifel Nicolaus increased their target price on Rocket Lab from $75.00 to $85.00 and gave the stock a “buy” rating in a research report on Monday, December 22nd. Finally, Bank of America lifted their price target on Rocket Lab from $50.00 to $60.00 and gave the company a “buy” rating in a research report on Wednesday, November 19th. Three equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Rocket Lab currently has a consensus rating of “Moderate Buy” and an average target price of $64.42.

Rocket Lab News Summary

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Morgan Stanley issued a large upgrade and raised its view on Rocket Lab, which triggered renewed buy-side interest and helped lift the stock. Rocket Lab Stock Jumps on Morgan Stanley Massive Upgrade
• Positive Sentiment: Large government/defense awards and a swelling backlog (previously reported) increase revenue visibility and support higher growth expectations for 2026 — a key fundamental driver underpinning the rally. Defense Contract Win Drives Shares to All-Time High
• Positive Sentiment: Research pieces and analyst commentary are lifting 2026 revenue expectations (one deep-dive projects roughly $900M), reinforcing the narrative that Rocket Lab is moving to a larger revenue tier as Defense & Space Systems backlog converts. Rocket Lab Enters A Different League
• Neutral Sentiment: Unusually heavy options activity — roughly 172,414 call contracts traded (about +18% vs. typical daily call volume) — signals speculative bullish positioning and can amplify intraday moves but doesn’t change fundamentals.
• Neutral Sentiment: Consensus broker view remains tilted toward buy/moderate-buy on average, keeping institutional interest and coverage high (Marketbeat consensus: “Moderate Buy”). Consensus “Moderate Buy” by Brokerages
• Negative Sentiment: KeyBanc downgraded RKLB from Overweight to Sector Weight citing valuation and potential “Neutron euphoria,” which triggered profit-taking earlier and remains a headwind. KeyBanc downgrades Rocket Lab (RKLB)
• Negative Sentiment: Insider sales by director Merline Saintil (large, recent disposals disclosed) can raise short-term concern about lockup monetization and add selling pressure. SEC Filing – Insider Sales
• Negative Sentiment: Several commentators warn the rally may be overextended; execution slips or Neutron timeline delays could trigger a large pullback given rich valuation multiples.

Insider Transactions at Rocket Lab

In other Rocket Lab news, SVP Arjun Kampani sold 28,615 shares of Rocket Lab stock in a transaction dated Monday, November 24th. The shares were sold at an average price of $40.65, for a total value of $1,163,199.75. Following the completion of the transaction, the senior vice president directly owned 461,014 shares of the company’s stock, valued at approximately $18,740,219.10. The trade was a 5.84% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Frank Klein sold 100,000 shares of the company’s stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $72.95, for a total transaction of $7,295,000.00. Following the completion of the transaction, the insider owned 1,169,487 shares in the company, valued at approximately $85,314,076.65. This represents a 7.88% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 4,306,150 shares of company stock worth $271,865,732 over the last quarter. Corporate insiders own 11.90% of the company’s stock.

Rocket Lab Price Performance

RKLB stock opened at $96.30 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.83 and a current ratio of 3.18. The firm has a 50 day moving average price of $61.54 and a 200-day moving average price of $54.23. Rocket Lab Corporation has a 52-week low of $14.71 and a 52-week high of $99.58. The firm has a market capitalization of $51.44 billion, a price-to-earnings ratio of -253.42 and a beta of 2.16.

Rocket Lab (NASDAQ:RKLB) last posted its quarterly earnings data on Monday, November 10th. The rocket manufacturer reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02. The company had revenue of $155.08 million during the quarter, compared to analyst estimates of $152.45 million. Rocket Lab had a negative return on equity of 27.26% and a negative net margin of 35.64%.The firm’s revenue for the quarter was up 48.0% on a year-over-year basis. During the same quarter last year, the company earned ($0.10) EPS. Equities research analysts forecast that Rocket Lab Corporation will post -0.38 EPS for the current fiscal year.

Rocket Lab Profile

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company’s primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company’s propulsion capabilities.